POET Technologies Reports Second Quarter Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
POET Technologies Reports Second Quarter Financial Results and Provides Outlook for Second Half 2016

SAN JOSE, Calif., Aug. 30, 2016 (GLOBE NEWSWIRE) -- POET Technologies Inc. (the “Company” or “POET”) (OTCQX:POETF) (TSX Venture:PTK), a developer of opto-electronics fabrication processes for the semiconductor industry, reported consolidated financial results for the period ended June 30, 2016. These interim financial results along with the Management Discussion and Analysis have been filed on SEDAR.

The Company reported sales of $576,741, which reflects six weeks of revenue from its acquisition of DenseLight Semiconductor on May 11, 2016. Reported sales represented 56% of the total sales of $1,037,882 in the first half of 2016 based on the unaudited financials of DenseLight.

First Half 2016 Highlights:

  • Launched joint 18-month development initiative with the Institute of Micro Electronics Engineering, a Singapore Agency for Science, Technology and Research for smart pixel applications specifically targeting the augmented reality market;
  • Successfully validated transfer of the POET Platform process to a 6-inch high volume production foundry;
  • Demonstrated a resonant cavity detector fabricated at the Company’s foundry supplier with superior performance.
  • Acquired DenseLight, a Singapore-based global provider of innovative photonic optical light source products and solutions to the communications, medical, instrumentations, industrial, defense, and security industries, as well as a cost-effective manufacturer of photonics products and services; and
  • Acquired BB Photonics Inc., a New Jersey company that is a designer of integrated photonic solutions for the data communications market.

“Through disciplined and focused execution, we continued to make solid progress during the quarter on our 2016 plan," said Suresh Venkatesan, Chief Executive Officer of POET Technologies.  "In addition to efforts to improve our operations, we made further progress on the development of the POET Platform during the quarter and were pleased to announce the first demonstrations of functional NHFETs on the integrated platform.  We are relentlessly focused on delivering shareholder value and expanding our R&D to capitalize on opportunities in current and new market segments.”

As previously announced, the acquisition of DenseLight and BB Photonics has added experienced engineers, IP and know-how, technologies, products as well as customers to the POET portfolio. With these strategic acquisitions, the Company is well positioned to offer differentiated IP and products to expand its reach in Data Communications (both within the Data Center and to Long Haul applications) and Photonic Sensing applications.  These acquisitions have expedited the Company’s roadmap to commercialization and revenue, while also providing direct and preferred access to a fab infrastructure for POET VCSEL and other product development, access to product sales and channel distribution networks, as well as a broader portfolio of photonic products.

Outlook for Second Half of 2016 POET expects revenue in the second half of 2016 to exceed $2,000,000, driven primarily by the increased sales of sensor products weighted toward the end of the year. The Company is unlocking the potential of a newly acquired portfolio of products, technology, fab operations, and customer base through investments in growth markets. POET plans to announce several new products in the second half of the year, which is expected to support continued growth into 2017. The Company also expects the DenseLight business unit to reach positive operating cash flow by the first quarter of 2017, helping to fund POET’s future product roadmap. 

Appointment of Investor Relations Counsel POET Technologies also announced that effective immediately the Company has appointed Shelton Group as the Company’s Investor Relations counsel, replacing the prior IR firm Robert Ferri Partners.

“The appointment of Shelton Group marks the next phase in POET’s goal to establish itself as a profitable growth company leveraging its unrivaled intellectual property in integrated opto-electronics technology,” said POET Chief Executive Officer Suresh Venkatesan. “Our entire team welcomes the Shelton Group, who has worked with a number of semiconductor companies over the past two decades.  We also appreciate the contributions of our previous IR counselors, and we thank them for their service.”

Jodi Shelton, Founder, CEO and President of Shelton Group, stated, “We are very pleased to have been selected by POET to manage their investor relations program. Shelton brings a wealth of experience and relevant industry knowledge to the partnership along with expansive relationships on the Street. We look forward to working with the Company’s management team and board to help bring expanded visibility to POET’s story and disruptive technology as the Company approaches a significant inflection point in their business.”

For more information about Shelton Group, please visit the company’s website at www.sheltongroup.com . The appointment is subject to approval of the TSX Venture Exchange.

About POET Technologies Inc. POET (Planar Opto-Electronic Technology) is a developer of opto-electronics and Photonic fabrication processes and products. Photonics integration is fundamental to increasing functional scaling and lowering the cost of current Photonic solutions.  POET believes that its advanced opto-electronics process platform enables substantial improvements in energy efficiency, component cost and size in the production of smart optical components, the engines driving applications ranging from data centers to consumer products to military applications. Silicon Valley-based POET’s patented module-on-a-chip process, which integrates digital, high-speed analog and optical devices on the same chip, is designed to serve as an industry standard for smart optical components. More information may be obtained at www.poet-technologies.com .

ON BEHALF OF THE BOARD OF DIRECTORS (signed) “John F. O’Donnell”, Secretary

For further information: Shelton Group Brett L. Perry P: +1-214-272-0070 Leanne K. Sievers P: +1-949-224-3874 E:  sheltonir@sheltongroup.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains “forward-looking information” (within the meaning of applicable Canadian securities laws) and “forward-looking statements” (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as “anticipate”, “believe”, “expect”, “plan”, “intend”, “potential”, “estimate”, “propose”, “project”, “outlook”, “foresee” or similar words suggesting future outcomes or statements regarding an outlook. Such statements include the Company’s expectations regarding :

  • the Company being well positioned to offer differentiated IP and products to expand its reach in Data Communications (both within the Data Center and to Long Haul applications) and Photonic Sensing applications;
  • the acquisitions having expedited the Company’s roadmap to commercialization and revenue, while also providing direct and preferred access to a fab infrastructure for POET VCSEL and other product development, access to product sales and channel distribution networks, as well as a broader portfolio of photonic products;
  • its expectation to double revenue over the first half of the year with sales exceeding $2,000,000, driven primarily by the increased sales of sensor products weighted toward the end of the year;
  • its plans to announce several new products in the second half of the year, which is expected to support continued growth into 2017; and
  • its expectations to reach positive operating cash flow in the DenseLight unit by the first quarter of 2017, helping to fund POET’s future product roadmap. 

They also include the Company’s expectations with respect to the capability, functionality, performance and cost of the Company’s technology.

Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Assumptions have been made regarding, among other things, management’s expectations regarding future growth, plans for and completion of projects by the Company’s third party relationships, availability of capital, and the necessity to incur capital and other expenditures. Actual results could differ materially due to a number of factors, including, without limitation, operational risks in the completion of the Company’s anticipated projects, delays or changes in plans with respect to the development of the Company’s anticipated projects by the Company’s third party relationships, risks affecting the Company’s ability to execute projects, the ability to attract key personnel, and the inability to raise additional capital. Although the Company believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Company’s securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward- looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law.

120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 - Fax: 416-322-5075

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 328

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 214

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Fabhalta® Breakthrough in PNH Treatment Showcased

Updated Category News Views 290

Novartis Fabhalta® Achieves Significant Hemoglobin Improvements In recent studies, Novartis has showcased promising results from its Phase IIIB APPULSE-PNH study regarding Fabhalta (iptacopan), designed for adult patients suffering from paroxysmal nocturnal hemoglobinuria (PNH). Patients who switched from anti-C5 therapies demonstrated noteworthy improvement in their...

Continue Reading
Insights into Indonesia's Economic Landscape for Credit Investors

Updated Category News Views 208

Understanding Indonesia's Market Dynamics This week, Gimme Credit unveiled a new Indonesia Country Report that delves into the recent fluctuations in the equity market and its potential ripple effects on foreign exchange and bond markets. The inquiry raises fundamental questions about whether these shifts could necessitate a higher risk premium for those investing in...

Continue Reading
Pliant Therapeutics to Showcase Innovations at Key Healthcare Conference

Updated Category News Views 187

Introduction to Pliant Therapeutics' Participation Pliant Therapeutics, Inc. (NASDAQ: PLRX), a dedicated force in the clinical-stage biotechnology sector, is set to make waves at an upcoming healthcare conference. The event serves as a platform for the company to showcase its integrin-based therapeutics—game-changing innovations aimed at treating various serious health...

Continue Reading
OSB Group PLC Financial Performance Overview for 2025

Updated Category News Views 322

OSB Group PLC Trading Update Summary OSB GROUP PLC, a specialist lending and retail savings group, is pleased to share its trading update for the nine-month period concluding on 30 September 2025. This report highlights the Group's steady growth and enhanced financial performance in line with expectations and strategic objectives. Performance Insights for the Nine-Month...

Continue Reading
Toll Brothers Unveils Luxurious Homes at Ridge Pointe Estates

Updated Category News Views 222

Toll Brothers Unveils New Luxury Homes at Ridge Pointe Estates Toll Brothers, Inc. (NYSE: TOL), recognized as a leader in the luxury home construction industry, has introduced its latest community, Ridge Pointe Estates. This community, now officially open, offers prospective homeowners a blend of elegance and modern living. Located within a serene setting, Ridge Pointe...

Continue Reading